Chemical inhibitors of RAPGEF5 target various aspects of its signaling pathway to achieve inhibition. NSC 23766 operates by disrupting the interaction between RAPGEF5 and Rac1, effectively obstructing the downstream signaling that is typically instigated by RAPGEF5's activation of Rac1. Similarly, EHop-016 focuses on Rac1 as well, but it directly binds to and inhibits Rac1 itself, which is a downstream effector of RAPGEF5. This binding leads to an indirect dampening of the signaling cascade that RAPGEF5 would normally propagate. ML141, another inhibitor, acts on Cdc42, which is a downstream target of RAPGEF5, by selectively inhibiting its activity and consequently attenuating the RAPGEF5-mediated signaling. CASIN inhibits C3G, a guanine nucleotide exchange factor related to RAPGEF5, which results in a reduction of RAPGEF5 signaling output. ZCL278 prevents RAPGEF5 from interacting with its substrate Cdc42, thereby decreasing the signaling capability of RAPGEF5.
CID44216842 selectively inhibits the binding of RAPGEF5 to its effector proteins, disrupting the downstream signaling processes that RAPGEF5 would otherwise facilitate. G15 antagonizes G protein-coupled receptor signaling, a pathway in which RAPGEF5 participates, leading to a consequent reduction in RAPGEF5 activity. Wiskostatin impedes the N-WASP-Arp2/3 complex, which operates downstream of RAPGEF5, consequently inhibiting the actin polymerization that RAPGEF5 would typically promote through its signaling. SecinH3 targets cytohesins, which share functional similarities with RAPGEF5 as guanine nucleotide exchange factors, thereby indirectly reducing RAPGEF5 GEF activity. Lastly, ITX3 targets Trio, another GEF which operates in a manner functionally akin to RAPGEF5, thereby indirectly curtailing the signaling functions that are usually attributed to RAPGEF5 through shared downstream effectors. Each of these chemicals, through their respective interactions, plays a role in the inhibition of RAPGEF5 signaling pathways, ensuring a comprehensive blockade of the protein's functional influence within cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits RAPGEF5 by preventing its activation of Rac1, thus hindering downstream signaling pathways which RAPGEF5 is known to regulate. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
Binds to and inhibits Rac1, a downstream effector of RAPGEF5, leading to an indirect inhibition of RAPGEF5-mediated signaling. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Acts as a selective inhibitor of Cdc42, downstream of RAPGEF5, thereby inhibiting RAPGEF5-mediated activation of Cdc42 and its signaling. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
Inhibits the activity of C3G, a guanine nucleotide exchange factor related to RAPGEF5, reducing the functional activity of RAPGEF5. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
Inhibits RAPGEF5 by preventing the interaction with its specific substrate Cdc42, leading to a decrease in its signaling function. | ||||||
CID-44216842 | 1222513-26-9 | sc-507406 | 5 mg | $285.00 | ||
Selectively inhibits the binding of RAPGEF5 to its effector proteins, thereby inhibiting downstream signaling processes. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits the N-WASP-Arp2/3 complex which is downstream of RAPGEF5, thereby indirectly inhibiting RAPGEF5-mediated actin polymerization. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits cytohesins, which are related to RAPGEF5 in their function as GEFs, thus indirectly inhibiting RAPGEF5's GEF activity. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
Inhibits Trio, a GEF functionally similar to RAPGEF5, indirectly reducing RAPGEF5-mediated signaling through shared downstream targets. | ||||||